What is Deep Medicine Acquisition Corp. (DMAQ)?

Deep Medicine Acquisition Corp. (DMAQ) is a stock in the Financial Services sector, Shell Companies industry. View full analysis on Stocks360.

What is the current price of DMAQ?

The current price of DMAQ is $2.96. Prices are updated in real time on Stocks360.

What is DMAQ's price-to-earnings (PE) ratio?

DMAQ's trailing twelve-month PE ratio is -0.09, based on current price and earnings per share data available on Stocks360.

What is DMAQ's market capitalization?

DMAQ's market capitalization is $12,899,562.00, placing it in the small-cap tier.

Deep Medicine Acquisition Corp. (DMAQ)

Stock analysis · NASDAQ · Financial Services · Shell Companies

$2.96

Market Cap

$12.90M

PE (TTM)

-0.09

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.02

Day Range

$2.96 – $7.69

52-wk Range

$2.96 – $19.91

Avg Volume

N/A

Volume

73.88K

Deep Medicine Acquisition Corp. (DMAQ) is a publicly traded company in the Financial Services sector. Latest price: $2.96. Market cap $12.90M. Trailing PE -0.09. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Deep Medicine Acquisition Corp.

Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies. The firm's strategic efforts are specifically concentrated on identifying promising enterprises within the healthcare industry. Incorporated in 2020, DMAQ maintains its principal place of business in New York, New York.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.09×
P/S (TTM)	0.63×
P/B	1.73×
P/FCF (TTM)	-10.78×
EV / EBITDA	12.93×
EV / Sales	0.57×
Earnings Yield	-346.08%
Free Cash Flow Yield	-9.28%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$11.56M
Revenue (TTM)	$20.36M
Net Income (TTM)	-$44.64M
Free Cash Flow (TTM)	-$5.51M
Net Debt	-$1.33M
Working Capital	-$2.35M
Gross Margin	54.39%
Operating Margin	-21.88%
Net Margin	-60.68%
Return on Equity	-292.09%
Return on Invested Capital	-53.23%